Hologic, Inc.  

(Public, NASDAQ:HOLX)   Watch this stock  
Find more results for HOLX
42.63
+0.10 (0.24%)
After Hours: 42.63 0.00 (0.00%)
Mar 29, 4:37PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 42.31 - 42.75
52 week 32.64 - 42.97
Open 42.41
Vol / Avg. 3.00M/2.30M
Mkt cap 11.85B
P/E 36.43
Div/yield     -
EPS 1.17
Shares 279.30M
Beta 1.09
Inst. own 100%
Mar 8, 2017
Hologic Inc Annual Shareholders Meeting
Mar 2, 2017
Hologic Inc Annual Shareholders Meeting (Estimated)
Jan 25, 2017
Q1 2017 Hologic Inc Earnings Release (Estimated)
Jan 10, 2017
Hologic Inc at JPMorgan Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin 11.78% 11.68%
Operating margin 19.88% 19.18%
EBITD margin - 36.16%
Return on average assets 4.73% 4.42%
Return on average equity 15.87% 15.67%
Employees 5,333 -
CDP Score - -

Address

250 Campus Dr
MARLBOROUGH, MA 01752-3020
United States - Map
+1-508-2632900 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women's health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays. It offers viral load assays for the quantitation of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human Immunodeficiency Virus-1 (HIV-1). The Breast Health products include breast imaging and related products and accessories, including digital mammography systems, computer-aided detection (CAD) and breast biopsy guidance systems. The GYN Surgical products include NovaSure Endometrial Ablation System and MyoSure Hysteroscopic Tissue Removal System. The Skeletal Health segment offers Discovery and Horizon X-ray bone densitometers and mini C-arm imaging systems.

Officers and directors

Stephen P. MacMillan Chairman of the Board, President, Chief Executive Officer
Age: 53
Bio & Compensation  - Reuters
Robert W. McMahon Chief Financial Officer
Age: 48
Bio & Compensation  - Reuters
Sanjay Prabhakaran Regional President - Asia
Bio & Compensation  - Reuters
Peter J. Valenti III Division President- Breast and Skeletal Health
Age: 53
Bio & Compensation  - Reuters
Jan Verstreken Regional President - Europe,Middle EastandAfrica(EMEA) and Canada
Bio & Compensation  - Reuters
Thomas A. West Division President- Diagnostics
Age: 53
Bio & Compensation  - Reuters
Eric B. Compton Chief Operating Officer
Age: 52
Bio & Compensation  - Reuters
Michael J. Watts Vice President, IR Contact Officer
Bio & Compensation  - Reuters
John M. Griffin General Counsel
Age: 56
Bio & Compensation  - Reuters
Elaine S. Ullian Lead Independent Director
Age: 69
Bio & Compensation  - Reuters